Log In
BCIQ
Print this Print this
 

TAB08

  Manage Alerts
Collapse Summary General Information
Company TheraMAB LLC
DescriptionHumanized IgG4 mAb targeting the T-lymphocyte co-stimulatory CD28 receptor
Molecular Target CD28 receptor
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today